Suman Shanker
Pfizer (United States)(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Immune Response and Inflammation, Glycosylation and Glycoproteins Research, Escherichia coli research studies, Immune Cell Function and Interaction
Most-Cited Works
- → Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay(2017)159 cited
- → Crystal structures of interleukin 17A and its complex with IL-17 receptor A(2013)141 cited
- → Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications(2014)131 cited
- → The catalytic mechanism of cyclic GMP‐AMP synthase (cGAS) and implications for innate immunity and inhibition(2017)67 cited
- → Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists(2016)60 cited
- → Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide(2016)55 cited
- → Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy(2015)25 cited
- → Unexpected mucin-type O-glycosylation and host-specific N-glycosylation of human recombinant interleukin-17A expressed in a human kidney cell line(2012)14 cited
- → Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccine(2025)8 cited
- → Discovery, Characterization, and Structure of a Cell Active PAD2 Inhibitor Acting through a Novel Allosteric Mechanism(2024)2 cited